XML 39 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The table below summarizes significant components of deferred tax assets and liabilities:
 December 31,
 20232022
Deferred tax assets  
Allowance for expected credit losses$7,597 $2,923 
Accrued vacation and bonus47,115 37,776 
Share-based compensation13,857 14,599 
Notes receivable from employees10,770 11,927 
State net operating loss carryforward172 537 
Foreign net operating and capital loss carryforward13,487 11,852 
Foreign tax credit carryforward14,384 4,199 
Deferred compensation3,550 3,049 
Operating lease assets64,649 64,465 
Employee benefits obligations568 519 
Other, net2,691 763 
Total deferred tax assets178,840 152,609 
Deferred tax liabilities
Revenue recognition(2,427)(6,406)
Operating lease liabilities(52,673)(51,995)
Property and equipment, net(13,216)(12,956)
Goodwill and intangible assets(207,131)(204,634)
Total deferred tax liabilities(275,447)(275,991)
Foreign withholding tax(2,178)(1,921)
Valuation allowance(6,773)(6,459)
Net deferred tax liabilities$(105,558)$(131,762)
As of December 31, 2023 and 2022, the Company recorded certain deferred tax assets related to foreign capital loss and foreign net operating loss carryforwards, which can be carried forward for periods ranging from 9 years to indefinite. Based on forward-looking financial information, the Company believes it is not more likely than not that the attributes will be utilized. Therefore, valuation allowances of $6.8 million and $6.5 million are recorded against the Company’s deferred tax assets as of December 31, 2023 and 2022, respectively.
As of December 31, 2022, a U.S. subsidiary of the Company (the “Licensor”) entered into an intellectual property license agreement with certain foreign subsidiaries of the Company in consideration of royalty payments that have been partially prepaid (the “License Agreement”). The License Agreement provides sufficient future taxable income in the U.S. to fully utilize the Company’s existing foreign tax credits in the U.S., which were previously subject to a valuation allowance.
The table below summarizes the components of income before income tax provision from continuing operations:
 Year Ended December 31,
 202320222021
Domestic$247,381 $165,553 $136,008 
Foreign110,982 132,196 161,939 
Total$358,363 $297,749 $297,947 
The table below summarizes the components of income tax provision from continuing operations:
 Year Ended December 31,
 202320222021
Current   
Federal$28,463 $24,227 $11,050 
State18,878 12,935 8,328 
Foreign38,029 34,917 37,656 
 85,370 72,079 57,034 
Deferred
Federal6,363 (2,717)10,766 
State(3,514)(1,173)3,458 
Foreign(4,748)(5,954)(8,277)
 (1,899)(9,844)5,947 
Income tax provision$83,471 $62,235 $62,981 
Our income tax provision from continuing operations resulted in effective tax rates that varied from the federal statutory income tax rate as summarized below:
 Year Ended December 31,
 202320222021
Income tax expense at federal statutory rate$75,256 $62,526 $62,569 
State income taxes, net of federal benefit12,562 10,486 8,643 
Detriment from foreign tax rates9,418 5,811 4,375 
Other expenses not deductible for tax purposes5,793 3,365 2,819 
Adjustment to reserve for uncertain tax positions(797)(609)2,665 
Share-based compensation(5,422)(9,372)(6,167)
Release of valuation allowance on foreign tax credits— (3,536)— 
Income tax benefit related to the License Agreement, net— (2,034)— 
Release of valuation allowance on Australian deferred tax asset— — (5,063)
U.S. foreign tax credits(9,464)(4,049)(4,859)
Valuation allowance on U.S. foreign tax credit carryforwards— — 3,536 
Deferred tax benefit of United Kingdom tax rate change— — (3,167)
Other adjustments, net(3,875)(353)(2,370)
Income tax provision$83,471 $62,235 $62,981 
The income tax provision for the years ended December 31, 2023 and 2022 was $83.5 million and $62.2 million, respectively. The increase in expense is primarily due to an increase in foreign taxes and a less favorable tax benefit related to share-based compensation as compared to 2022 due to fewer shares vesting, which was partially offset by a foreign tax credit benefit.
A portion of the increase of the 2023 effective tax rate was related to the 2022 $9.6 million tax benefit related to the release of a U.S. foreign tax credit valuation allowance which did not recur in 2023, utilization of current year foreign tax credits and a deferred tax benefit arising from an intellectual property license agreement between a U.S. subsidiary of the Company and certain foreign subsidiaries of the Company.
We file numerous consolidated and separate income tax returns in the U.S. federal jurisdiction and in many city, state and foreign jurisdictions. We are no longer subject to U.S. federal income tax examinations for years prior to 2017. We are also no longer subject to state and local or foreign tax examinations by tax authorities for years prior to 2015.
Our liability for uncertain tax positions was $1.6 million and $3.2 million as of December 31, 2023 and 2022, respectively. As of December 31, 2023, our accrual for the payment of tax-related interest and penalties was not significant